Clariant’s shareholders approve all agenda items - Seite 2
Conrad Keijzer, Chief Executive Officer of Clariant, added: “Thanks to the effective implementation of our performance programs and strong margin management, we achieved a robust performance in 2023. Our improved operational efficiencies and the benefits derived from the acquisition of Lucas Meyer Cosmetics will drive profitable growth in 2024 and beyond.”
Further, Dr. Balthasar Settelen, attorney, was reelected as independent proxy until the next Annual General Meeting, and KPMG was confirmed as the statutory auditor for 2024.
The proposal for total compensation of the Board of Directors for the term from the 2024 to the 2025 Annual General Meeting was approved with 98.69 % of the votes, as was the total compensation of the Executive Steering Committee for the 2025 fiscal year, with 91.41 % of the votes.
Lesen Sie auch
Please find additional documents related to the AGM available for download on https://www.clariant.com/agm
CORPORATE MEDIA RELATIONS Jochen Dubiel Phone +41 61 469 63 63 jochen.dubiel@clariant.com Ellese Caruana Phone +41 61 469 63 63 ellese.caruana@clariant.com Luca Lavina Phone +41 61 469 63 63 luca.lavina@clariant.com Follow us on X, Facebook, LinkedIn, Instagram. |
INVESTOR RELATIONS Andreas Schwarzwälder Phone +41 61 469 63 73 andreas.schwarzwaelder@clariant.com Thijs Bouwens Phone +41 61 469 63 73 thijs.bouwens@clariant.com |
This media release contains certain statements that are neither reported financial results nor other historical information. This document also includes forward-looking statements. Because these forward-looking statements are subject to risks and uncertainties, actual future results may differ materially from those expressed in or implied by the statements. Many of these risks and uncertainties relate to factors that are beyond Clariant’s ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behavior of other market participants, the actions of governmental regulators and other risk factors such as: the timing and strength of new product offerings; pricing strategies of competitors; the company’s ability to continue to receive adequate products from its vendors on acceptable terms, or at all, and to continue to obtain sufficient financing to meet its liquidity needs; and changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, including currency fluctuations, inflation and consumer confidence, on a global, regional or national basis. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this document. Clariant does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date of these materials. |